Jump to:



Lyxumia: once-daily injection for type II diabetes

Lyxumia (lixisenatide) is a once-daily parenteral hypoglycaemic for the management of uncontrolled type II diabetes in combination with oral hypoglycaemics and/or insulin.

New Drugs

Lyxumia: once-daily injection for type II diabetes

Lyxumia (lixisenatide) is a once-daily parenteral hypoglycaemic for the management of uncontrolled...

Dymista: new intranasal rhinitis treatment

The nasal spray Dymista is now available for the treatment of perennial...

Perjeta: new option for HER2-positive breast cancer

Perjeta (pertuzumab) is licensed for HER2-positive metastatic or locally recurrent unresectable breast...

Zaltrap: new treatment option for metastatic colorectal cancer

Zaltrap (aflibercept) is licensed for the treatment of metastatic colorectal cancer that...

Zoely: combined oral contraceptive containing new progestogen

Zoely is the first combined oral contraceptive to use nomegestrol as its...

Licence Changes & Product Updates

Ixiaro: first Japanese encephalitis vaccine approved for paediatric use in the UK

Children aged 2 months and older can now receive the Japanese encephalitis...

Onglyza approved for triple oral therapy

Onglyza (saxagliptin) can now be used in combination with metformin and a...

Isosorbide mononitrate shortage

The Department of Health has notified healthcare professionals of a supply issue...

Abilify: use in bipolar disorder extended

Abilify is now indicated for the treatment of moderate to severe manic...

Fostair now for maintenance and reliever therapy in asthma

Fostair (formoterol/beclometasone) can now be prescribed for patients with asthma who require...

Guidelines & Clinical Updates

GMC updates prescribing guidance

The General Medical Council (GMC) has published new guidance for all doctors...

Abatacept now approved for rheumatoid arthritis after failure of conventional DMARDs

Following a review, NICE have overturned their previous negative decision for abatacept...

NICE updates guidance and extends use of omalizumab in severe allergic asthma

Omalizumab (Xolair) has been accepted by NICE for broader use in the...

First targeted treatment for idiopathic pulmonary fibrosis approved by NICE

Patients with idiopathic pulmonary fibrosis can now benefit from the novel treatment...

Dopaminergic medication associated with impulse control disorders

Impulse control disorders such as pathological gambling, compulsive shopping or eating, increased...


Other Related News

GPs handed urgent care role in bid to tackle A&E crisis

GPs could be handed an expanded role in urgent care under an...

Quarter of patients want power to delete medical records

GPs fear online access to medical data will put records at risk...

#weekinreview - 9 May: A&E crisis latest, penis problems and #KFintegratedcare

A glance back over this week's primary care news, opinion, top tweets...

GPs cannot be NHS 'border agency'

GP leaders have warned the government against making doctors a new 'border...

GMC says new rules will speed up hearings

The GMC has introduced a new set of rules that it claims...

Latest MIMS Guidelines Summaries

Prevention of Cardiovascular Disease - Summary of Joint British Societies' Guidelines

Recommended assessments, management approaches and targets.

Initiating Treatment with Transdermal Opioids

Guidance on appropriate dosing when starting fentanyl or buprenorphine patches in opioid-naive...

Opioid Analgesics: Approximate Potency Equivalence with Oral Morphine

Guide to relative potencies of opioid analgesics to aid dose conversion when...

Prescribing of Strong Opioids for Pain in Palliative Care of Adults - NICE Guideline

At-a-glance summary of NICE advice on prescribing opioids. Adapted from: NICE Clinical...

Clinical Management of Primary Hypertension in Adults

Diagnosis and treatment of high blood pressure, as recommended by NICE. Adapted...


MIMS Specialist Journals

Now available on www.mimsmx.com

Click here to view

2-Part CME Diabetes Program

This activity will explore the latest data on the SGLT-2 inhibitors and implications for practice. Click here.

MIMS app

Access the full MIMS database from your mobile device

Click here to find out more

MIMs Drug Search

Possible searches include drugs (by brand, generic ingredient or drug class), diseases and more.

Find drugs by:

Travel Vaccination & Malaria Advice

Travel Vaccination & Malaria Advice

Supplied by the National
Travel Health Network
and Centre (NaTHNaC)

Palliative Care Resources

Palliative Care Resources

Opioid dose conversions
and much more

Childhood Immunisation

Childhood Immunisation

Summary of routine
vaccination schedule

Referral Guidelines for Breast Disorders

Referral Guidelines for Breast Disorders

MIMS Summary of NHS Cancer Screening Referral Guidelines

Back to top